Skip to content
lifestyle.utv.ie
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Alumis Inc.
Alumis Announces New Phase 3 Data Demonstrating Envudeucitinib Rapidly and Durably Improved Psoriasis Burden Across Scalp, Itch, and Quality of Life Measures
October 9, 2026
Alumis to Participate in Upcoming September Investor Conferences
September 4, 2026
Alumis Announces Topline Results from Envudeucitinib Phase 2b Trial in Systemic Lupus Erythematosus (SLE)
September 1, 2026
Alumis Reports Second Quarter 2026 Financial Results and Highlights Recent Achievements
August 13, 2026
Envudeucitinib Long-term Data Positioned to Set a New Standard for Plaque Psoriasis Treatment, Delivering Highest Reported PASI 100 Skin Clearance Among Oral Therapies
August 10, 2026
Alumis Reports First Quarter 2026 Financial Results and Highlights Recent Achievements
May 15, 2026
Alumis to Participate in Upcoming February Investor Conferences
February 10, 2026